204 related articles for article (PubMed ID: 31150422)
21. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.
Lin CL; Hsu YC; Huang YT; Shih YH; Wang CJ; Chiang WC; Chang PJ
EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30948420
[TBL] [Abstract][Full Text] [Related]
22. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
23. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
25. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
[TBL] [Abstract][Full Text] [Related]
26. Loss of Sirt1 promotes exosome secretion from podocytes by inhibiting lysosomal acidification in diabetic nephropathy.
Ding L; Li ZL; Zhou Y; Liu NC; Liu SS; Zhang XJ; Liu CC; Zhang DJ; Wang GH; Ma RX
Mol Cell Endocrinol; 2023 Jun; 568-569():111913. PubMed ID: 36990198
[TBL] [Abstract][Full Text] [Related]
27. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
28. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
29. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
30. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
[TBL] [Abstract][Full Text] [Related]
31. Sestrin2 remedies podocyte injury via orchestrating TSP-1/TGF-β1/Smad3 axis in diabetic kidney disease.
Song S; Shi C; Bian Y; Yang Z; Mu L; Wu H; Duan H; Shi Y
Cell Death Dis; 2022 Jul; 13(7):663. PubMed ID: 35908070
[TBL] [Abstract][Full Text] [Related]
32. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
33. Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
Ma X; Schwarz A; Sevilla SZ; Levin A; Hultenby K; Wernerson A; Lal M; Patrakka J
J Am Soc Nephrol; 2018 Jun; 29(6):1679-1689. PubMed ID: 29636387
[No Abstract] [Full Text] [Related]
34. Semaphorin3a promotes advanced diabetic nephropathy.
Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
[TBL] [Abstract][Full Text] [Related]
35. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.
Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X
J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809
[TBL] [Abstract][Full Text] [Related]
36. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
37. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
[TBL] [Abstract][Full Text] [Related]
38. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
[TBL] [Abstract][Full Text] [Related]
39. IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy.
Kuo HL; Huang CC; Lin TY; Lin CY
Nephrol Dial Transplant; 2018 Feb; 33(2):248-256. PubMed ID: 28339909
[TBL] [Abstract][Full Text] [Related]
40. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
Khan S; Jena G; Tikoo K; Kumar V
Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]